E & L USA : Extractables & Leachables : [conference proceedings] : delivering pharmaceuticals safely : 7-9 May 2013, Providence, RI, USA /
I tiakina i:
| Ngā kaituhi rangatōpū: | , |
|---|---|
| Hōputu: | Tāhiko Mauhanga Hui īPukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
Providence, RI :
Smithers Information Ltd.,
2013.
|
| Ngā marau: | |
| Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
Extractables & Leachables : [E & L 2012 conference proceedings] : delivering pharmaceuticals safely : 12-13 December 2012, Vienna, Austria /
I whakaputaina: (2012)
I whakaputaina: (2012)
Extractables & Leachables for Pharmaceutical Products 2011 : [conference proceedings] : Dublin, Ireland, 27-28 September 2011 /
I whakaputaina: (2011)
I whakaputaina: (2011)
Manufacturing of pharmaceutical proteins : from technology to economy /
mā: Behme, Stefan
I whakaputaina: (2015)
mā: Behme, Stefan
I whakaputaina: (2015)
Biodiversity new leads for the pharmaceutical and agrochemical industries /
I whakaputaina: (2000)
I whakaputaina: (2000)
Forecasting for the pharmaceutical industry models for new product and in-market forecasting and how to use them /
mā: Cook, Arthur G.
I whakaputaina: (2006)
mā: Cook, Arthur G.
I whakaputaina: (2006)
Innovation and the pharmaceutical industry critical reflections on the virtues of profit /
I whakaputaina: (2008)
I whakaputaina: (2008)
The pharmaceutical studies reader /
I whakaputaina: (2015)
I whakaputaina: (2015)
Medicines as a service a new commercial model for big pharma in the postblockbuster world /
mā: Mattke, Soeren
I whakaputaina: (2012)
mā: Mattke, Soeren
I whakaputaina: (2012)
Supply chain management in the drug industry delivering patient value for pharmaceuticals and biologics /
mā: Rees, Hedley
I whakaputaina: (2011)
mā: Rees, Hedley
I whakaputaina: (2011)
Risk management applications in pharmaceutical and biopharmaceutical manufacturing
I whakaputaina: (2013)
I whakaputaina: (2013)
Devalued and distrusted can the pharmaceutical industry restore its broken image? /
mā: LaMattina, John L.
I whakaputaina: (2013)
mā: LaMattina, John L.
I whakaputaina: (2013)
Glocal pharma : international brands and the imagination of local masculinity /
mā: Johnson, Ericka
I whakaputaina: (2016)
mā: Johnson, Ericka
I whakaputaina: (2016)
Portfolio, program, and project management in the pharmaceutical and biotechnology industries
I whakaputaina: (2010)
I whakaputaina: (2010)
Pharmaceutical and biomedical project management in a changing global environment
I whakaputaina: (2010)
I whakaputaina: (2010)
Understanding drugs markets : an analysis of medicines, regulations, and pharmaceutical systems in the global south /
I whakaputaina: (2022)
I whakaputaina: (2022)
Successfully marketing clinical trial results winning in the healthcare business /
mā: Umbach, Günter
I whakaputaina: (2006)
mā: Umbach, Günter
I whakaputaina: (2006)
Towards drugs of the future key issues in lead finding and lead optimization /
I whakaputaina: (2008)
I whakaputaina: (2008)
WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report.
I whakaputaina: (2003)
I whakaputaina: (2003)
WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /
I whakaputaina: (2014)
I whakaputaina: (2014)
Pharmaceutical blending and mixing /
I whakaputaina: (2015)
I whakaputaina: (2015)
Coherence for health innovation for new medicines for infectious diseases.
I whakaputaina: (2009)
I whakaputaina: (2009)
Pharmaceutical pricing policies in a global market
I whakaputaina: (2008)
I whakaputaina: (2008)
Pharmaceutical industry innovation and developments /
I whakaputaina: (2011)
I whakaputaina: (2011)
Regulating pharmaceuticals in Europe striving for efficiency, equity and quality /
I whakaputaina: (2004)
I whakaputaina: (2004)
Les prix des medicaments sur un marche global politiques et enjeux.
I whakaputaina: (2008)
I whakaputaina: (2008)
Leachables and extractables handbook safety evaluation, qualification, and best practices applied to inhalation drug products /
I whakaputaina: (2012)
I whakaputaina: (2012)
Therapeutic targets modulation, inhibition, and activation /
I whakaputaina: (2012)
I whakaputaina: (2012)
The agile approach to adaptive research optimizing efficiency in clinical development /
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
Building a national framework for the establishment of regulatory science for drug development workshop summary /
I whakaputaina: (2011)
I whakaputaina: (2011)
Quality assurance of pharmaceuticals a compendium of guidelines and related materials. Volume 2, Good manufacturing practices and inspection.
I whakaputaina: (2007)
I whakaputaina: (2007)
Pharmaceutical innovation and access to medicines /
I whakaputaina: (2018)
I whakaputaina: (2018)
The greening of pharmaceutical engineering. practice, analysis, and methodology /
mā: Islam, Rafiqul, 1959-
I whakaputaina: (2015)
mā: Islam, Rafiqul, 1959-
I whakaputaina: (2015)
Negotiating health : intellectual property and access to medicines /
I whakaputaina: (2006)
I whakaputaina: (2006)
Innovation in the biopharmaceutical industry
I whakaputaina: (2007)
I whakaputaina: (2007)
The power of pills social, ethical and legal issues in drug development, marketing, and pricing /
I whakaputaina: (2006)
I whakaputaina: (2006)
Pharmaceutical lifecycle management making the most of each and every brand /
mā: Ellery, Tony
I whakaputaina: (2012)
mā: Ellery, Tony
I whakaputaina: (2012)
Organelle-specific pharmaceutical nanotechnology
I whakaputaina: (2010)
I whakaputaina: (2010)
Outsourcing clinical development strategies for working with CROs and other partners /
I whakaputaina: (2006)
I whakaputaina: (2006)
Analysis of aggregates and particles in protein pharmaceuticals
I whakaputaina: (2012)
I whakaputaina: (2012)
Emerging safety science workshop summary /
I whakaputaina: (2008)
I whakaputaina: (2008)